ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
120.211,12
0,07%
S&P 500
5.868,55
0,00%
US Dollar vs BRL
6,1515
-0,02%
Bitcoin
96.497,28
-0,41%
Brent Oil
75,97
0,15%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Enveric Biosciences Inc (ENVB)

  7. Enveric Biosciences Inc (ENVB) Notícias

ENVB

Enveric Biosciences (ENVB)

Enveric Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ENVB
DataHoraFonteTítuloCódigoCompanhia
18/12/202410:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ENVBEnveric Biosciences Inc
12/12/202414:04Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:ENVBEnveric Biosciences Inc
02/12/202410:00Business WireEnveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series CompoundsNASDAQ:ENVBEnveric Biosciences Inc
27/11/202418:36Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ENVBEnveric Biosciences Inc
25/11/202411:00Business WireEnveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like BehaviorNASDAQ:ENVBEnveric Biosciences Inc
22/11/202418:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
14/11/202418:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ENVBEnveric Biosciences Inc
14/11/202418:05Business WireEnveric Biosciences Reports Third Quarter 2024 Financial and Corporate ResultsNASDAQ:ENVBEnveric Biosciences Inc
13/11/202413:18Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ENVBEnveric Biosciences Inc
12/11/202411:00Business WireEnveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002NASDAQ:ENVBEnveric Biosciences Inc
04/11/202412:36Business WireEnveric Biosciences Announces Broad Range of Patent IssuancesNASDAQ:ENVBEnveric Biosciences Inc
15/10/202409:00Business WireEnveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003NASDAQ:ENVBEnveric Biosciences Inc
11/10/202420:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENVBEnveric Biosciences Inc
26/09/202409:30Business WireEnveric Biosciences Presents Data Highlighting Development of EB-003 at European Behavioral Pharmacology Society Biennial WorkshopNASDAQ:ENVBEnveric Biosciences Inc
25/09/202409:30Business WireEnveric Biosciences Presents Data on Lead Product Candidate, EB-003, at 7th Neuropsychiatric Drug SummitNASDAQ:ENVBEnveric Biosciences Inc
12/09/202410:35Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ENVBEnveric Biosciences Inc
12/09/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ENVBEnveric Biosciences Inc
04/09/202419:43Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ENVBEnveric Biosciences Inc
04/09/202409:00Business WireEnveric Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ENVBEnveric Biosciences Inc
13/08/202409:00Business WireAries Science & Technology and Enveric Biosciences Announce Issuance of Key US Patent Under Aries’ License for Treatment of Radiation Dermatitis and Other ConditionsNASDAQ:ENVBEnveric Biosciences Inc
12/08/202418:30Business WireEnveric Biosciences Reports Second Quarter 2024 Financial and Corporate ResultsNASDAQ:ENVBEnveric Biosciences Inc
25/07/202409:00Business WireEnveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed OrallyNASDAQ:ENVBEnveric Biosciences Inc
15/07/202410:02Business WireAries Science & Technology and Enveric Biosciences Announce Licensing AgreementNASDAQ:ENVBEnveric Biosciences Inc
10/07/202409:00Business WireEnveric Biosciences Announces Patent Granted for Drug CandidateNASDAQ:ENVBEnveric Biosciences Inc
08/07/202418:10Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ENVBEnveric Biosciences Inc
25/06/202409:00Business WireEnveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development CandidateNASDAQ:ENVBEnveric Biosciences Inc
03/06/202419:58Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ENVBEnveric Biosciences Inc
30/05/202409:00Business WireEnveric Biosciences to Participate in BIO International Convention 2024NASDAQ:ENVBEnveric Biosciences Inc
15/05/202407:00Business WireEnveric Biosciences Reports First Quarter 2024 Financial and Corporate ResultsNASDAQ:ENVBEnveric Biosciences Inc
14/05/202409:00Business WireEnveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health DisordersNASDAQ:ENVBEnveric Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ENVB

Seu Histórico Recente

BIT
P1R0C8
BNP Paribas Issuance
BIT
P1H511
BNP Paribas Issuance
NASDAQ
ABKEQXX
Bofa Finance Llc Autocal...
NYSE
ACAQ.WS
Athena Consumer Acquisit...
BOV
ALLD3R
Allied Tecnologia ON
BIT
P1RI94
BNP Paribas Issuance
BIT
S29006
Societe Generale Effekten
BIT
3MIB
GraniteShares 3x Long MI...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados